NCT00303797 2013-03-19Sorafenib and Bortezomib in Treating Patients With Advanced CancerNational Cancer Institute (NCI)Phase 1 Completed50 enrolled
NCT00004241 2013-02-0717-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaNational Cancer Institute (NCI)Phase 1 Completed60 enrolled
NCT00132015 2012-03-1517-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic MastocytosisNational Institutes of Health Clinical Center (CC)Phase 2 Completed37 enrolled
NCT00004075 2011-08-0317-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By SurgeryMayo ClinicPhase 1 Completed